Question 1

What is SACUBITRIL AND VALSARTAN used for?

Accepted Answer

SACUBITRIL AND VALSARTAN is a ARB indicated for 1 INDICATIONS AND USAGE ENTRESTO is a combination of sacubitril, a neprilisin inhibitor, and valsartan.

Question 2

How does SACUBITRIL AND VALSARTAN work?

Accepted Answer

SACUBITRIL AND VALSARTAN works through the following mechanism: 12.1 Mechanism of Action ENTRESTO contains a neprilysin inhibitor, sacubitril, and an angiotensin receptor blocker, valsartan. ENTRESTO inhibits neprilysin (neutral endopeptidase; NEP) via LBQ657, the active metabolite of the prodrug sacubitril, and blocks the angiotensin II type-1 (AT 1 ) receptor via valsartan. The cardiovascular and renal effects of ENTRESTO in heart failure patients are attributed to the increased levels of peptides that are degraded by neprilysin, such as natriuretic peptides, by LBQ657, and the simultaneous inhibition of the effects of angiotensin II by valsartan. Valsartan inhibits the effects of angiotensin II by selectively blocking the AT 1 receptor, and also inhibits angiotensin II-dependent aldosterone release..

Question 3

What are the most common side effects of SACUBITRIL AND VALSARTAN?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for SACUBITRIL AND VALSARTAN. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is SACUBITRIL AND VALSARTAN the same as its brand-name version?

Accepted Answer

SACUBITRIL AND VALSARTAN is the generic name. The active ingredient is the same across any brand-name or generic versions approved by the FDA.

SACUBITRIL AND VALSARTAN

Mechanism of Action

Indications

FDA Warnings

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations